Violation Tracker Individual Record

Company: 
U.S. Bioservices Corporation
Current Parent Company: 
AmerisourceBergen
Penalty: 
$13,400,000
Year: 
2017
Date: 
September 7, 2017
Offense Group: 
competition-related offenses
Primary Offense: 
kickbacks and bribery
Violation Description: 

U.S. Bioservices agreed to pay $13.4 million to settle multistate allegations that it recommended the drug Exjade to Medicaid patients in exchange for kickbacks from Novartis Pharmaceuticals Corporation, which marketed the drug.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
USA
HQ State of Parent: 
Pennsylvania
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
wholesalers
Specific Industry of Parent: 
wholesalers-pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.